AnPac Bio-Medical Science Statistics Share Statistics AnPac Bio-Medical Science has 6.27M
shares outstanding. The number of shares has increased by 0%
in one year.
Shares Outstanding 6.27M Shares Change (YoY) 0% Shares Change (QoQ) 0% Owned by Institutions (%) n/a Shares Floating 6.04M Failed to Deliver (FTD) Shares 1,588 FTD / Avg. Volume 7.2%
Short Selling Information The latest short interest is 26.01K, so 0% of the outstanding
shares have been sold short.
Short Interest 26.01K Short % of Shares Out n/a Short % of Float n/a Short Ratio (days to cover) 1
Valuation Ratios The PE ratio is -0.6 and the forward
PE ratio is null.
AnPac Bio-Medical Science's PEG ratio is
0.01.
PE Ratio -0.6 Forward PE n/a PS Ratio 5.12 Forward PS n/a PB Ratio -4.51 P/FCF Ratio -1.09 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for AnPac Bio-Medical Science.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 0.32,
with a Debt / Equity ratio of -0.9.
Current Ratio 0.32 Quick Ratio 0.32 Debt / Equity -0.9 Debt / EBITDA -0.16 Debt / FCF -0.22 Interest Coverage -225.57
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee $135.33K Profits Per Employee $-1.16M Employee Count 89 Asset Turnover 0.3 Inventory Turnover 17.66
Taxes Income Tax -2.13M Effective Tax Rate 2.01%
Stock Price Statistics The stock price has increased by -1.6% in the
last 52 weeks. The beta is 1.56, so AnPac Bio-Medical Science's
price volatility has been higher than the market average.
Beta 1.56 52-Week Price Change -1.6% 50-Day Moving Average 5.57 200-Day Moving Average 5.37 Relative Strength Index (RSI) 37.53 Average Volume (20 Days) 22,069
Income Statement In the last 12 months, AnPac Bio-Medical Science had revenue of 12.04M
and earned -103.6M
in profits. Earnings per share was -54.18.
Revenue 12.04M Gross Profit 8.34M Operating Income -84.14M Net Income -103.6M EBITDA -78.4M EBIT -105.36M Earnings Per Share (EPS) -54.18
Full Income Statement Balance Sheet The company has 1.87M in cash and 12.31M in
debt, giving a net cash position of -10.44M.
Cash & Cash Equivalents 1.87M Total Debt 12.31M Net Cash -10.44M Retained Earnings -577.54M Total Assets n/a Working Capital n/a
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -55.06M
and capital expenditures -1.59M, giving a free cash flow of -56.65M.
Operating Cash Flow -55.06M Capital Expenditures -1.59M Free Cash Flow -56.65M FCF Per Share -29.63
Full Cash Flow Statement Margins Gross margin is 69.21%, with operating and profit margins of -698.59% and -860.16%.
Gross Margin 69.21% Operating Margin -698.59% Pretax Margin -877.85% Profit Margin -860.16% EBITDA Margin -650.95% EBIT Margin -698.59% FCF Margin -470.38%
Dividends & Yields ANPC does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for ANPC.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Nov 4, 2022. It was a
backward
split with a ratio of 1:20.
Last Split Date Nov 4, 2022 Split Type backward Split Ratio 1:20
Scores Altman Z-Score n/a Piotroski F-Score n/a
